ADMA

ADMA BIOLOGICS INC

Healthcare | Mid Cap

$0.19

EPS Forecast

$138.6

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

$0.19

Revenue Forecast:

$138.6

EPS Surprise Forecast:

$0.002

Revenue Surprise Forecast:

-$1

Post-release price volatility - High

Post-release Overnight Move:

±8.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

54%

Probability of beating revenue consensus:

47%

Probability of beating both EPS & revs consensus:

32%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

0.63

Earnings volatility

EPS standard deviation:

$0.11

Revenue standard deviation:

$23

As % of share price:

1.08% VERY HIGH

As % of market cap:

1.00% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.34

Revenue 95th %ile:

$168

EPS 75th %ile:

$0.23

Revenue 75th %ile:

$146

EPS 25th %ile:

$0.16

Revenue 25th %ile:

$132

EPS 5th %ile:

$0.07

Revenue 5th %ile:

$114

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

45% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$16

Bid-ask per Share:

$0.015